Related references
Note: Only part of the references are listed.Rosuvastatin Reduces Neuroinflammation in the Hemorrhagic Transformation After rt-PA Treatment in a Mouse Model of Experimental Stroke
Dan Lu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke
Jieli Geng et al.
BRAIN EDEMA XVI: TRANSLATE BASIC SCIENCE INTO CLINICAL PRACTICE (2016)
Adverse Effects of Statins - Myths and Reality
Iveta Simic et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Statins in Acute Ischemic Stroke: A Systematic Review
Keun-Sik Hong et al.
JOURNAL OF STROKE (2015)
Consensus Statement on the Use of Intravenous Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke by the Chinese Stroke Therapy Expert Panel
An-Ding Xu et al.
CNS Neuroscience & Therapeutics (2013)
The THRombolysis and STatins (THRaST) study
Manuel Cappellari et al.
NEUROLOGY (2013)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Edward C. Jauch et al.
STROKE (2013)
Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis
Sergi Martinez-Ramirez et al.
JOURNAL OF NEUROLOGY (2012)
Sequence-specific MR Imaging Findings That Are Useful in Dating Ischemic Stroke
Laura M. Allen et al.
RADIOGRAPHICS (2012)
Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study
Manuel Cappellari et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Statin Use and Functional Outcome after Tissue Plasminogen Activator Treatment in Acute Ischaemic Stroke
I. Miedema et al.
CEREBROVASCULAR DISEASES (2010)
Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke
M. Uyttenboogaart et al.
JOURNAL OF NEUROLOGY (2008)
Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator
Jose Alvarez-Sabin et al.
STROKE (2007)
Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials
Joan Marti-Fabregas et al.
CEREBROVASCULAR DISEASES (2007)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells
T Bourcier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
